Tannu Sahay, M.D.

3.2 times the Medicare Part D claims of the average hematology & oncology physician in 2024

2,774 Medicare Part D claims for 451 beneficiaries, against an average of 877 among the 10,784 providers of this specialty who prescribed in Part D. Brand-name drugs were 20% of claims. 17 claims were for opioids.

Most prescribed

1. Letrozole323 claims
2. Acyclovir171 claims
3. Hydroxyurea156 claims
4. Anastrozole152 claims
5. Prochlorperazine Maleate148 claims
6. Dexamethasone147 claims

Source: CMS Medicare Part D Prescribers by Provider and Drug, 2024 (data.cms.gov). Part D covers prescriptions for Medicare patients only; drugs with fewer than 11 claims are not published.

The practice group's MIPS final score for 2023 (Medicare payment program): 77.9 of 100

The Merit-based Incentive Payment System score is reported for the practice group, not for one clinician alone. Four categories are weighted into the final score; the average among 454,083 clinicians with a measured score was 83.5.

Source: CMS Quality Payment Program, MIPS performance year 2023, group reporting; category weights for 2023 (qpp.cms.gov).

One hospital affiliation

1. Mymichigan Medical Center AlmaAlma, MI · Acute Care Hospitals4 of 5 stars

Source: CMS Doctors and Clinicians National Downloadable File (the group practices a clinician bills Medicare through); hospitals matched to CMS Hospital General Information (Care Compare) (data.cms.gov). Star ratings are CMS hospital ratings, not ratings of this provider.